Capital Fund Management (CFM)’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,175
| Closed | -$752K | – | 954 |
|
|
2019
Q4 | $752K | Buy |
12,175
+4,175
| +52% | +$258K | 0.01% | 565 |
|
|
2019
Q3 | $481K | Buy |
8,000
+1,800
| +29% | +$108K | ﹤0.01% | 563 |
|
|
2019
Q2 | $523K | Buy |
+6,200
| New | +$523K | ﹤0.01% | 521 |
|
|
2018
Q4 | – | Sell |
-4,100
| Closed | -$350K | – | 912 |
|
|
2018
Q3 | $350K | Buy |
+4,100
| New | +$350K | ﹤0.01% | 739 |
|
|
2015
Q1 | – | Sell |
-5,100
| Closed | -$259K | – | 753 |
|
|
2014
Q4 | $259K | Buy |
+5,100
| New | +$259K | ﹤0.01% | 613 |
|